Fidelity Investments’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-11,422
| Closed | -$103K | – | 5575 |
|
|
2025
Q4 | $103K | Sell |
11,422
-1,580
| -12% | -$11.8K | ﹤0.01% | 3743 |
|
|
2025
Q3 | $40.4K | Sell |
13,002
-444
| -3% | -$1.18K | ﹤0.01% | 4073 |
|
|
2025
Q2 | $28.8K | Sell |
13,446
-29,620
| -69% | -$47.8K | ﹤0.01% | 4140 |
|
|
2025
Q1 | $49.5K | Buy |
43,066
+5,943
| +16% | +$10.2K | ﹤0.01% | 3865 |
|
|
2024
Q4 | $81.3K | Sell |
37,123
-93,763
| -72% | -$212K | ﹤0.01% | 3641 |
|
|
2024
Q3 | $285K | Buy |
130,886
+3,854
| +3% | +$8.86K | ﹤0.01% | 3075 |
|
|
2024
Q2 | $293K | Sell |
127,032
-251,589
| -66% | -$1.05M | ﹤0.01% | 2909 |
|
|
2024
Q1 | $2.08M | Buy |
378,621
+309,138
| +445% | +$1.41M | ﹤0.01% | 2326 |
|
|
2023
Q4 | $172K | Sell |
69,483
-8,608,046
| -99% | -$81.8M | ﹤0.01% | 3011 |
|
|
2023
Q3 | $301M | Buy |
8,677,529
+124,298
| +1% | +$4.3M | 0.03% | 553 |
|
|
2023
Q2 | $281M | Buy |
8,553,231
+948,890
| +12% | +$32.7M | 0.02% | 597 |
|
|
2023
Q1 | $255M | Buy |
7,604,341
+5,909,854
| +349% | +$230M | 0.02% | 617 |
|
|
2022
Q4 | $55.6M | Sell |
1,694,487
-201,325
| -11% | -$5.96M | 0.01% | 1215 |
|
|
2022
Q3 | $65.4M | Buy |
1,895,812
+319,870
| +20% | +$7.08M | 0.01% | 1134 |
|
|
2022
Q2 | $19.3M | Buy |
1,575,942
+758,903
| +93% | +$11.3M | ﹤0.01% | 1663 |
|
|
2022
Q1 | $11.1M | Buy |
817,039
+3,367
| +0.4% | +$45K | ﹤0.01% | 2076 |
|
|
2021
Q4 | $16.2M | Buy |
+813,672
| New | +$15.4M | ﹤0.01% | 1919 |
|
Other funds holding VTYX
Fidelity Investments's VTYX Position: Q1 2026 in Review
Fidelity Investments sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 11,422 shares — an estimated $103K sold.
Fidelity Investments first reported a position in VTYX in Q4 2021 and held it in 17 quarters. The position peaked at $301M in Q3 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.
- Fidelity Investments reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
- Fidelity Investments sold 11,422 Ventyx Biosciences shares in Q1 2026, an estimated $103K.
- Fidelity Investments first reported a position in Ventyx Biosciences in Q4 2021 and held it in 17 quarters.
- Fidelity Investments's Ventyx Biosciences position peaked at $301M in Q3 2023.
- 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.